Start free

Monopar Therapeutics (MNPR) insider trading

Recent insider transactions reported to the SEC on Form 4 — directors and officers buying or selling their own company’s stock. Sourced directly from public SEC filings, latest filed Nov 4, 2026.

Filings shown
15
Open-market buys
0
Open-market sells
25

Counts cover the 15 most recent Form 4 filings Tradune holds for MNPR (filed Jun 30 – Nov 4, 2026); the score below covers only the trailing 90 days (0 buys, 25 sells). SEC EDGAR Form 4 filings for MNPR last checked Nov 22, 2026, 09:00 UTC; the latest MNPR filing Tradune holds was filed Nov 4, 2026. This is not guaranteed to be the complete record — see MNPR's full Form 4 filing history on SEC EDGAR.

Open-market activity, last 90 days

Purchases (Form 4 code P) and sales (code S) on the 11 filings Tradune holds for MNPR filed Aug 27 – Nov 4, 2026. Grants, exercises, tax withholding and the other Form 4 transaction codes are left out.

25 open-market sales by Rule 10b5-1 checkbox

On filings with the 10b5-1 box checked
25 sales· 51,921 sh
checkbox disclosed
On filings with the box not checked
0 sales· 0 sh
not proof that no plan exists
Not comparable
0 sales· 0 sh
filed before Apr 1, 2023, or no checkbox value in the filing data

Counts are Form 4 lines as filed. The checkbox is one per filing, so every sale on a filing with the box checked is counted there even if only some of its transactions were under a plan; it records what the filer disclosed, and the three categories are not a judgement about why a sale was made.

Open-market purchases and sales by insider
Insider Buys Sells Shares bought Shares sold Value
Kim R. TsuchimotoDirector 0 10 — 8,180 −$745,628
Raymond AndersonDirector 0 7 — 6,284 −$566,582
Chandler RobinsonChief Executive Officer 0 4 — 29,056 −$2,556,851
Christopher M. StarrDirector 0 3 — 8,400 −$659,387
Patrice RiouxInsider 0 1 — 1 −$111

Value = shares × the price reported on each Form 4 (+ purchases, − sales); every open-market line in this window disclosed a price.

Insider-activity score

0/ 100

Net insider sales
0 distinct buyers0 buy · 25 sell tx

Summarises ~90 days of public SEC Form 4 activity — more distinct buyers, officer involvement and net buying score higher. A description of filing activity, not a rating or buy signal. How this score is computed →

Get alerted when insiders buy the stocks you own

Add your holdings — no brokerage login — and Insider Radar sends a Telegram alert when an open-market Form 4 buy of $100,000 or more is filed on a stock you hold or watch.

Free for everyone right now · no card · nothing to buy

Start free

How to read this: an open-market purchase (Form 4 code P) is a buy at the market price with the insider’s own money, as opposed to a grant, award or option exercise; an open-market sale is code S. When two or more distinct insiders report open-market purchases in the same 90-day window, this site labels that a cluster — a definition, not a forecast; see insider cluster buying. “Held after” is Form 4 Table I column 5; “Change” = shares ÷ holdings before the trade (held after − shares for an acquisition, held after + shares for a disposition).

Insider Buying at MNPR

No open-market insider purchases (Form 4 code P) were reported for MNPR between Jun 30, 2026 and Nov 4, 2026. The filings below may include other transaction types — sales, grants, option exercises, and tax withholding — shown for completeness; they are not open-market purchases.

Recent Form 4 filings

Source: SEC EDGAR Form 4 · transaction codes explained

Kim R. Tsuchimoto Director · filed Nov 4, 2026 · SEC ↗
TransactionSharesPriceHeld afterChange†Date
Option exercise 2,035 $14.00 2,891 +238% Nov 4, 2026
Open-market sale 10b5-1 box checked 1,295 $70.75 1,596 −45% Nov 4, 2026
Open-market sale 10b5-1 box checked 996 $71.35 600 −62% Nov 4, 2026
Open-market sale 10b5-1 box checked 600 $72.21 0 −100% Nov 4, 2026
Option exercise 856 $30.00 856 — Nov 4, 2026
Option exercise Stock Option 856 — — — Nov 4, 2026
Option exercise Stock Option 2,035 — — — Nov 4, 2026
Option exercise 1,199 $30.00 1,199 — Nov 2, 2026
Open-market sale 10b5-1 box checked 1,199 $70.10 0 −100% Nov 2, 2026
Option exercise Stock Option 1,199 — — — Nov 2, 2026

† change in this filer’s own reported holding line (Form 4 Table I, col. 5), not of total company ownership; small prior holdings produce large percentages, so under 100 shares the prior holding is shown instead.

“10b5-1 box checked” = the filer checked the Form 4 box stating that a transaction on the filing was made under a plan intended to satisfy Rule 10b5-1(c); “10b5-1 box not checked” = the box was left blank, which does not prove that no plan exists. The box applies to Form 4s filed from April 1, 2023; older filings, and boxes we could not read, carry no tag. What the 10b5-1 box means.

Raymond Anderson Director · filed Nov 4, 2026 · SEC ↗
TransactionSharesPriceHeld afterChange†Date
Open-market sale 10b5-1 box checked 600 $67.06 7,075 −7.8% Nov 2, 2026
Open-market sale 10b5-1 box checked 200 $68.68 6,875 −2.8% Nov 2, 2026
Open-market sale 10b5-1 box checked 1,502 $70.04 5,373 −22% Nov 2, 2026
Option exercise Stock Option 1,402 — — — Nov 2, 2026
Option exercise Stock Option 1,740 — — — Nov 2, 2026
Option exercise 1,402 $30.00 6,775 +26% Nov 2, 2026
Option exercise 1,740 $30.00 8,515 +26% Nov 2, 2026
Open-market sale 10b5-1 box checked 840 $66.16 7,675 −9.9% Nov 2, 2026
Chandler Robinson Chief Executive Officer · filed Oct 20, 2026 · SEC ↗
TransactionSharesPriceHeld afterChange†Date
Tax withholding 597 $92.59 104,127 −0.6% Oct 20, 2026
Christopher M. Starr Director · filed Oct 5, 2026 · SEC ↗
TransactionSharesPriceHeld afterChange†Date
Option exercise Stock Option 8,400 — — — Oct 1, 2026
Open-market sale 10b5-1 box checked 799 $79.67 5,173 −13% Oct 1, 2026
Open-market sale 10b5-1 box checked 2,970 $78.82 5,972 −33% Oct 1, 2026
Open-market sale 10b5-1 box checked 4,631 $78.09 8,942 −34% Oct 1, 2026
Option exercise 8,400 $0.01 13,573 +162% Oct 1, 2026
Andrew Cittadine Chief Operating Officer · filed Oct 2, 2026 · SEC ↗
TransactionSharesPriceHeld afterChange†Date
Option exercise 4,384 — 59,998 +7.9% Sep 30, 2026
Tax withholding 1,944 $79.67 58,054 −3.2% Sep 30, 2026
Option exercise Restricted Stock Unit 4,384 — — — Sep 30, 2026
Chandler Robinson Chief Executive Officer · filed Oct 2, 2026 · SEC ↗
TransactionSharesPriceHeld afterChange†Date
Option exercise 9,801 — 109,068 +9.9% Sep 30, 2026
Tax withholding 4,344 $79.67 104,724 −4.0% Sep 30, 2026
Option exercise Restricted Stock Unit 9,801 — — — Sep 30, 2026
Quan Anh Vu Chief Financial Officer · filed Oct 2, 2026 · SEC ↗
TransactionSharesPriceHeld afterChange†Date
Option exercise 614 — 2,835 +28% Sep 30, 2026
Tax withholding 180 $79.67 2,655 −6.3% Sep 30, 2026
Option exercise Restricted Stock Unit 614 — — — Sep 30, 2026
Chandler Robinson Chief Executive Officer · filed Sep 28, 2026 · SEC ↗
TransactionSharesPriceHeld afterChange†Date
Option exercise Stock Option 14,056 — — — Sep 24, 2026
Option exercise Stock Option 15,000 — — — Sep 24, 2026
Option exercise 14,056 $30.00 113,323 +14% Sep 24, 2026
Option exercise 15,000 $14.00 128,323 +13% Sep 24, 2026
Open-market sale 10b5-1 box checked 10,450 $87.15 117,873 −8.1% Sep 24, 2026
Open-market sale 10b5-1 box checked 9,638 $87.96 108,235 −8.2% Sep 24, 2026
Open-market sale 10b5-1 box checked 8,368 $88.97 99,867 −7.7% Sep 24, 2026
Open-market sale 10b5-1 box checked 600 $89.79 99,267 −0.6% Sep 24, 2026
Kim R. Tsuchimoto amended Director · filed Aug 28, 2026 · SEC ↗
TransactionSharesPriceHeld afterChange†Date
Open-market sale 10b5-1 box checked 485 $108.83 3,605 −12% Aug 26, 2026
Open-market sale 10b5-1 box checked 700 $110.65 2,290 −23% Aug 26, 2026
Open-market sale 10b5-1 box checked 1,098 $111.84 1,192 −48% Aug 26, 2026
Open-market sale 10b5-1 box checked 602 $112.93 590 −51% Aug 26, 2026
Open-market sale 10b5-1 box checked 590 $113.84 0 −100% Aug 26, 2026
Option exercise Stock Option 2,055 — — — Aug 26, 2026
Option exercise Stock Option 2,035 — — — Aug 26, 2026
Option exercise 2,055 $30.00 2,055 — Aug 26, 2026
Option exercise 2,035 $14.00 4,090 +99% Aug 26, 2026
Open-market sale 10b5-1 box checked 615 $109.56 2,990 −17% Aug 26, 2026
Raymond Anderson amended Director · filed Aug 28, 2026 · SEC ↗
TransactionSharesPriceHeld afterChange†Date
Option exercise 1,740 $30.00 8,515 +26% Aug 25, 2026
Open-market sale 10b5-1 box checked 646 $111.07 7,175 −8.3% Aug 25, 2026
Open-market sale 10b5-1 box checked 1,802 $113.05 5,373 −25% Aug 25, 2026
Option exercise Stock Option 1,402 — — — Aug 25, 2026
Option exercise Stock Option 1,740 — — — Aug 25, 2026
Option exercise 1,402 $30.00 6,775 +26% Aug 25, 2026
Open-market sale 10b5-1 box checked 694 $110.04 7,821 −8.2% Aug 25, 2026
Patrice Rioux Insider · filed Aug 27, 2026 · SEC ↗
TransactionSharesPriceHeld afterChange†Date
Option exercise Stock Option 1,380 — — — Aug 26, 2026
Open-market sale 10b5-1 box checked 1 $111.26 5,065 −0.0% Aug 26, 2026
Option exercise 1,380 $0.01 5,066 +37% Aug 26, 2026
Quan Anh Vu Chief Financial Officer · filed Jul 2, 2026 · SEC ↗
TransactionSharesPriceHeld afterChange†Date
Option exercise 1,228 — 2,728 +82% Jun 30, 2026
Tax withholding 507 $92.59 2,221 −19% Jun 30, 2026
Option exercise Restricted Stock Unit 1,228 — — — Jun 30, 2026
Chandler Robinson Chief Executive Officer · filed Jul 2, 2026 · SEC ↗
TransactionSharesPriceHeld afterChange†Date
Option exercise Restricted Stock Unit 12,873 — — — Jun 30, 2026
Tax withholding 4,084 $92.59 99,267 −4.0% Jun 30, 2026
Option exercise 12,873 — 103,351 +14% Jun 30, 2026
Andrew Cittadine Chief Operating Officer · filed Jul 2, 2026 · SEC ↗
TransactionSharesPriceHeld afterChange†Date
Option exercise Restricted Stock Unit 5,254 — — — Jun 30, 2026
Tax withholding 2,309 $92.59 55,614 −4.0% Jun 30, 2026
Option exercise 5,254 — 57,923 +10.0% Jun 30, 2026
Nicole Sweeny Director · filed Jun 30, 2026 · SEC ↗
TransactionSharesPriceHeld afterChange†Date
Grant / award Stock Options 1,284 — — — Jun 26, 2026

Insider filings reported around the same time

Other companies whose most recent Form 4 was filed closest to MNPR's (Nov 4, 2026).

Frequently asked about MNPR insider activity

How many insiders bought MNPR stock in these Form 4 filings?

No open-market purchases (Form 4 code P) of MNPR shares were reported by Monopar Therapeutics insiders between Jun 30, 2026 and Nov 4, 2026. The 15 filings shown on this page cover other transaction types — sales, grants, option exercises, and tax withholding.

Who filed the most recent Form 4 for MNPR?

The most recent Form 4 on this page was filed by Raymond Anderson (Director) on Nov 4, 2026, reporting 8 transactions. The original document is linked from the filing list above on SEC EDGAR. Amended filings (Form 4/A) may later revise reported figures.

What was the largest open-market MNPR insider sale shown?

The largest open-market sale among the filings shown was 10,450 MNPR shares at $87.15 (about $910,718) by Chandler Robinson (Chief Executive Officer) on Sep 24, 2026. Value is shares × the price reported on the Form 4; that Form 4 has the Rule 10b5-1 box checked.

New to Form 4s? The transaction codes, the 90-day window and the 0–100 score are defined on the insider-activity score methodology page.

Get insider alerts for MNPR — and your whole portfolio

Tradune watches SEC Form 4 filings and flags insider-cluster buying across everything you hold, routed to you automatically. Free for everyone right now · no card · nothing to buy

This score summarizes SEC Form 4 filing activity over the trailing 90 days. It is descriptive, not predictive — not a rating, recommendation, or investment advice. Data: SEC EDGAR (public domain), as filed; amendments may revise figures. Tradune is not a registered investment adviser.

Data as filed; amended filings (Form 4/A) may revise figures. Sales may occur under prearranged Rule 10b5-1 trading plans.